全文获取类型
收费全文 | 55724篇 |
免费 | 908篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 378篇 |
儿科学 | 3455篇 |
妇产科学 | 1501篇 |
基础医学 | 3979篇 |
口腔科学 | 1815篇 |
临床医学 | 3075篇 |
内科学 | 13013篇 |
皮肤病学 | 949篇 |
神经病学 | 2912篇 |
特种医学 | 1323篇 |
外科学 | 10312篇 |
综合类 | 2989篇 |
预防医学 | 6154篇 |
眼科学 | 951篇 |
药学 | 2364篇 |
12篇 | |
中国医学 | 236篇 |
肿瘤学 | 1295篇 |
出版年
2023年 | 197篇 |
2022年 | 429篇 |
2021年 | 1008篇 |
2020年 | 535篇 |
2019年 | 7961篇 |
2018年 | 6132篇 |
2017年 | 2901篇 |
2016年 | 346篇 |
2015年 | 393篇 |
2014年 | 1238篇 |
2013年 | 943篇 |
2012年 | 1018篇 |
2011年 | 1084篇 |
2010年 | 909篇 |
2009年 | 775篇 |
2008年 | 701篇 |
2007年 | 676篇 |
2006年 | 505篇 |
2005年 | 440篇 |
2004年 | 371篇 |
2003年 | 305篇 |
2002年 | 230篇 |
2001年 | 223篇 |
2000年 | 196篇 |
1999年 | 168篇 |
1998年 | 129篇 |
1997年 | 146篇 |
1996年 | 85篇 |
1995年 | 62篇 |
1994年 | 68篇 |
1993年 | 22篇 |
1992年 | 26篇 |
1991年 | 22篇 |
1990年 | 14篇 |
1989年 | 15篇 |
1988年 | 17篇 |
1985年 | 2180篇 |
1984年 | 3278篇 |
1983年 | 2320篇 |
1982年 | 2549篇 |
1981年 | 2434篇 |
1980年 | 2155篇 |
1979年 | 2219篇 |
1978年 | 1940篇 |
1977年 | 1427篇 |
1976年 | 1744篇 |
1975年 | 1502篇 |
1974年 | 1332篇 |
1973年 | 1307篇 |
1972年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
6.
7.
《The ocular surface》2020,18(1):108-113
PurposeAromatase inhibitors (AIs) limit the synthesis of oestrogen in peripheral tissues thus lowering levels of oestrogen. The primary aim was to evaluate whether women treated with AIs have altered dry eye symptoms and signs. A sub-aim was to investigate whether symptoms of dry eye in postmenopausal women were associated with symptoms of non-eye pain, ocular pain and self-rated pain perception.MethodsThis cross-sectional, observational, single visit study recruited 56 postmenopausal women (mean age 64.1 + 7.9 years) and 52 undergoing AI treatment (mean age 66.6 + 9.0). Ocular symptoms (OSDI, MGD14) and pain questionnaires (PSQ, OPAS) were administered and signs of dry eye and meibomian gland dysfunction were evaluated.ResultsAlmost half of each group reported dry eye symptoms, defined as OSDI>12 (48% control, 46% AI). The PSQ score was significantly higher in the AI group (p = 0.04). Neither frequency or severity of dry eye (or MGD) symptoms scores were significantly different between groups. In the AI group, meibomian gland expressibility score was worse (p = 0.003); there were no differences in any other signs. Higher OSDI scores were associated with higher OPAS eye-pain scores (r = 0.49, p < 0.001), but not OPAS non-eye pain (r = 0.09, p = 0.35). Pain perception (PSQ) showed a moderate positive association with OPAS eye-pain (r = 0.30, p = 0.003).ConclusionsIn this study elevated ocular symptoms were observed in both the AI treated and the untreated groups, with no difference between the groups. Women undergoing AI treatment for early stage breast cancer had worse meibum expressibility score and increased pain perception compared to an untreated group of women. 相似文献
8.
9.
Ngai-Yin Chan Chi-Chung Choy Ho-Chuen Yuen Hoi-Fan Chow Ho-Fai Fong 《The Canadian journal of cardiology》2019,35(4):396-404
Background
Persistent iatrogenic atrial septal defect (iASD) is a common but poorly characterized complication after cryoballoon (CB) pulmonary vein isolation (PVI) procedures. We therefore investigate its prevalence, evolution, risk factors, and clinical outcomes in a prospective longitudinal study.Methods
A total of 108 patients (41 women, mean age 57 ± 11.3) underwent CB PVI for AF. Serial transesophageal echocardiography (TEE) was performed 9 months and then annually until 6 years after the procedure to study the characteristics of persistent iASD.Results
Persistent iASD occurred in 33 (30.6%) patients 9 months after CB PVI. Spontaneous closure of iASD was found in 6 (22.2%) and 3 (15.8%) patients 2 and 3 years after the procedures, respectively. No spontaneous closure was observed on 4, 5, and 6-year TEE follow-up. The projected long-term persistence rate of iASD after CB PVI was therefore 20% (30.6% × 0.778 × 0.842). Using multivariate logistic regression, a higher number of cryoapplications (≥ 2 minutes) was the only independent predictor of persistent iASD 9 months after CB PVI (odds ratio [OR] 1.207; 95% confidence interval [CI], 1.033-1.411, P = 0.018). Two (1.9%) patients with significantly larger iASD size than the others (long diameter 12.6 ± 0.8 vs 3.7 ± 1.5 mm, P < 0.001; short diameter 10.9 ± 0.2 vs 3 ± 1.1 mm, P < 0.001) required percutaneous closure because of exertional dyspnea and right ventricular enlargement. Over 129.7 patient-years follow-up, during which iASD persisted, there was no occurrence of neurologic events.Conclusions
Approximately one fifth of patients undergoing CB PVI will have permanently persistent iASD. Patients with defect sizes of greater than 10 mm may need percutaneous closure due to significant left-to-right shunting. 相似文献10.